首页> 外文期刊>Genomics >Genomic aspects of NAFLD pathogenesis
【24h】

Genomic aspects of NAFLD pathogenesis

机译:NAFLD发病机理的基因组方面

获取原文
           

摘要

Non-alcoholicfattyliverdisease(NAFLD)isthemostpredominantliverdiseaseworldwideandhepaticmanifestationofthemetabolicsyndrome.Itshistologyspectrumrangesfromsteatosis,tosteatohepatitis(NASH)thatcanfurtherprogresstocirrhosisandhepatocellularcarcinoma(HCC).TheincreasingincidenceofNAFLDhascontributedtorisingnumbersofHCCoccurrences.NAFLDprogressionisgovernedbygeneticsusceptibility,environmentalfactors,lifestyleandfeaturesofthemetabolicsyndrome,manyofwhichoverlapwithHCC.GeneexpressionprofilingandgenomewideassociationstudieshaveidentifiednoveldiseasepathwaysandpolymorphismsingenesthatmaybepotentialbiomarkersofNAFLDprogression.However,themultifactorialnatureofNAFLDandthelimitednumberofsufficientlypoweredstudiesareamongthecurrentlimitationsforvalidatedbiomarkersofclinicalutility.Furtherstudiesincorporatingthelinksbetweencircadianregulationandhepaticmetabolismmightrepresentanadditionaldirectioninthesearchforpredictivebiomarkersofliverdiseaseprogressionandtreatmentoutcomes./p/div
机译:非alcoholicfattyliverdisease(NAFLD)isthemostpredominantliverdiseaseworldwideandhepaticmanifestationofthemetabolicsyndrome.Itshistologyspectrumrangesfromsteatosis,tosteatohepatitis(NASH)thatcanfurtherprogresstocirrhosisandhepatocellularcarcinoma(HCC).TheincreasingincidenceofNAFLDhascontributedtorisingnumbersofHCCoccurrences.NAFLDprogressionisgovernedbygeneticsusceptibility,environmentalfactors,lifestyleandfeaturesofthemetabolicsyndrome,manyofwhichoverlapwithHCC.GeneexpressionprofilingandgenomewideassociationstudieshaveidentifiednoveldiseasepathwaysandpolymorphismsingenesthatmaybepotentialbiomarkersofNAFLDprogression.However,themultifactorialnatureofNAFLDandthelimitednumberofsufficientlypoweredstudiesareamongthecurrentlimitationsforvalidatedbiomarkersofclinicalutility.Furtherstudiesincorporatingthelinksbetweencircadianregulationandhepaticmetabolismmightrepresentanadditionaldirectioninthesearchforpredictivebiomarkersofliverdiseaseprogressionandtreatmentoutcomes。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号